Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.
© 2024 TechCrunch. All rights reserved. For personal use only.
from TechCrunch https://ift.tt/taDMAjmSam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.
© 2024 TechCrunch. All rights reserved. For personal use only.
from TechCrunch https://ift.tt/taDMAjmShortly after Amazon announced its $50 billion investment in OpenAI, AWS invited me on a private tour of the chip lab at the heart of the de...
No comments:
Post a Comment